MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Clinical trial NCT07479485 · RECRUITING

Trial details

NCT number: NCT07479485
Sponsor: Lepu Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2026-04-08
Primary completion: 2028-04-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.